| Ytd | -65.46% | |
| 1y | -40.83% |
| Open | 3.74 | Prev Close | 3.76 | Low | 3.64 | High | 3.92 | Mkt Cap | 44.39M |
| Vol | 167.23K | Avg Vol | 359.14K | EPS | -16.62 | P/E | N/A | Forward P/E | -0.86 |
| Beta | 2.21 | Short Ratio | 1.76 | Inst. Own | 4.13% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 05-15 | 50-d Avg | 3.77 | 200-d Avg | 8.06 | 1yr Est | 0.00 |
Gainers Adicet Bio (NASDAQ:ACET) stock moved upwards by 22.9% to $10.14 during Thursday's pre-m
The granted patent includes claims directed to the proprietary IHL-42X composition and its associate
MELBOURNE, Australia and NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (Nasda
Incannex Healthcare Inc. (NASDAQ:IXHL) ("Incannex" or the "Company"), a clinical-sta
Alliance Global Partners analyst James Molloy initiates coverage on Incannex Healthcare (NASDAQ:I